MedPath

A French Multi-centric Atrial Fibrillation Catheter Ablation Survey

Conditions
Observation of Outcome After Catheter Ablation of Atrial Fibrillation
Registration Number
NCT01918670
Lead Sponsor
Clinique Pasteur
Brief Summary

Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a procedure that is currently used for the treatment of symptomatic atrial fibrillation patients.

We have organized a multi-centric national survey of catheter ablation of atrial fibrillation in order to have a feedback on the type of procedures being performed and the overall results (freedom of atrial fibrillation) over an average follow-up of 18 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • all patients undergoing catheter ablation of atrial fibrillation or left atrial flutter
Exclusion Criteria
  • patients undergoing catheter ablation of other types of arrhythmia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Atrial fibrillation relapsestarting 3 months after the procedure till an average of 18months follow-up

Documentation of atrial fibrillation relapse (symptomatic or asymptomatic) after the first 3 months after the index procedure

Secondary Outcome Measures
NameTimeMethod
Early atrial fibrillation relapsefirst 3 months

Documented atrial fibrillation relapse (symptomatic or asymptomatic) in the first 3 months after the index procedure

Trial Locations

Locations (1)

Clinique Pasteur

🇫🇷

Toulouse, France

Clinique Pasteur
🇫🇷Toulouse, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.